New results from a COVID-19 vaccine trial in South Africa suggest the vaccine that was developed by AstraZeneca may not be as effective against the variant found there.
South Africa Halts AstraZeneca COVID-19 Vaccine Trial
New results from a COVID-19 vaccine trial in South Africa suggest the vaccine that was developed by AstraZeneca may not be as effective against the variant found there.
0 comments:
Post a Comment